🇺🇸 FDA
Pipeline program

Placebo of IPN10200, IPN10200

CLIN-10200-457

Phase 2 small_molecule active

Quick answer

Placebo of IPN10200, IPN10200 for Cervical Dystonia is a Phase 2 program (small_molecule) at Ipsen Pharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Ipsen Pharma
Indication
Cervical Dystonia
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials